These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 580590)

  • 21. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status of cardiac glycoside drug interactions.
    Hooymans PM; Merkus FW
    Clin Pharm; 1985; 4(4):404-13. PubMed ID: 2412751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Formulas for the simplified calculation of the effective level of glycosides in heart therapy].
    Mitzkat HJ; Bronsert U
    Int J Clin Pharmacol; 1972 Apr; 6(1):88-91. PubMed ID: 5048675
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cardiac glycoside therapy].
    Born H
    Folia Clin Int (Barc); 1969 Nov; 17(11):534-45. PubMed ID: 5803723
    [No Abstract]   [Full Text] [Related]  

  • 25. Current drug therapy: cardiac glycosides.
    Am J Hosp Pharm; 1978 Dec; 35(12):1495-507. PubMed ID: 362913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serum half-life and renal clearance of 3H peruvoside. Study on normal persons and patients with terminal kidney insufficiency].
    Kramer P; Willms B; Horenkamp J; Scheler F
    Verh Dtsch Ges Kreislaufforsch; 1969; 35():440-4. PubMed ID: 5380625
    [No Abstract]   [Full Text] [Related]  

  • 27. [Possibilities and problems or long-term therapy using cardiac glycosides].
    Gillmann H
    Z Gesamte Inn Med; 1973 Feb; 28(3):41-5 passim. PubMed ID: 4633782
    [No Abstract]   [Full Text] [Related]  

  • 28. [Gitoformate and digitoxin as alternatives to kidney-dependent glycosides in the therapy of cardiac insufficiency].
    Rietbrock N; Woodcock BG; Hrazdil U
    Arzneimittelforschung; 1984; 34(8):915-7. PubMed ID: 6541927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on the pharmacokinetics of meproscillarin (author's transl)].
    Belz GG; Belz G
    Arzneimittelforschung; 1978; 28(3a):535-9. PubMed ID: 580584
    [No Abstract]   [Full Text] [Related]  

  • 30. Kinetic analysis of D-xylose absorption in normal subjects and in patients with chronic renal failure.
    Craig RM; Murphy P; Gibson TP; Quintanilla A; Chao GC; Cochrane C; Patterson A; Atkinson AJ
    J Lab Clin Med; 1983 Mar; 101(3):496-506. PubMed ID: 6827177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Enteral availability and therapeutic activity of proscillaridin-4'-methyl ether (author's transl)].
    Krämer KD; Hochrein H
    Arzneimittelforschung; 1976 Apr; 26(4):579-83. PubMed ID: 989015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Optimization of therapy using cardiac glycosides].
    Ziesenhenn K; Behn P
    Z Gesamte Inn Med; 1978 Nov; 33(22):830-3. PubMed ID: 746673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical study of the biological availability of lanatoside C and digoxin in long-term tests].
    Bodem G; Ochs H; Hahn E; Dengler HJ
    Schweiz Med Wochenschr; 1977 May; 107(19):658-66. PubMed ID: 867012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bioavailability of digoxin and beta-methyl-digoxin in patients with liver and gastro-intestinal diseases ].
    Hess T; Bütler A; Stucki P
    Wien Klin Wochenschr; 1982 May; 94(10):251-8. PubMed ID: 7123952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy with cardiac glycosides].
    Simon H
    Hippokrates; 1976 Feb; 47(1):30-52. PubMed ID: 783095
    [No Abstract]   [Full Text] [Related]  

  • 36. [Recent aspects of therapy with cardiac glycosides].
    Bayer O; Jost F
    Dtsch Med J; 1970 May; 21(10):675-6 passim. PubMed ID: 5523167
    [No Abstract]   [Full Text] [Related]  

  • 37. [Rational prescription of cardiac stimulants].
    Rietbrock N; Abshagen U; von Bergmann K; Kewitz H
    Dtsch Med J; 1972 Feb; 23(2):100-5. PubMed ID: 5017962
    [No Abstract]   [Full Text] [Related]  

  • 38. Digitalis therapy in renal failure with special regard to digitoxin.
    Vöhringer HF; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):175-84. PubMed ID: 7021432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [On the clinical trial of a heart and coronary drug].
    Eisel K; Kaiser H
    Ther Ggw; 1968 Feb; 107(2):231-2 passim. PubMed ID: 5718464
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of the sugar component in cardiac glycosides on their action in patients with auricular fibrillation and congestive failure.
    Gold H; Kwit NT; Shane SJ; Dayrit C
    J Clin Pharmacol J New Drugs; 1969; 9(3):148-54. PubMed ID: 5255179
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.